#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14822	16S	1529	1529	99.87	16S.l15.c30.ctg.1	2051	718.9	0	.	n	.	0	A69G	SNP	69	69	A	300	300	G	835	G,T	756,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14822	16S	1529	1529	99.87	16S.l15.c30.ctg.1	2051	718.9	0	.	n	.	0	C1450T	SNP	1450	1450	C	1681	1681	T	817	T	749	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14822	16S	1529	1529	99.87	16S.l15.c30.ctg.1	2051	718.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1415	1415	C	912	C,T	837,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26936	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3583	750.0	0	.	n	.	0	T695C	SNP	695	695	T	1035	1035	C	844	C,T	771,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26936	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3583	750.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2311	2311	C	849	C	758	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26936	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3583	750.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2385	2385	A	817	A	749	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26936	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3583	750.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2937	2937	C	842	C	785	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2016	folP	855	855	100.0	folP.l15.c4.ctg.1	1424	140.8	1	SNP	p	R229S	1	.	.	685	687	AGC	959	961	AGC	202;204;205	A;G;C	183;186;183	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5924	gyrA	2751	2751	100.0	gyrA.l6.c30.ctg.1	3341	176.9	1	SNP	p	S91F	1	.	.	271	273	TTC	565	567	TTC	186;187;185	T;T,C;C,T	169;169,1;170,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5924	gyrA	2751	2751	100.0	gyrA.l6.c30.ctg.1	3341	176.9	1	SNP	p	G95N	0	.	.	283	285	GGC	577	579	GGC	184;185;189	G;G,A;C	168;169,1;173	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5924	gyrA	2751	2751	100.0	gyrA.l6.c30.ctg.1	3341	176.9	1	SNP	p	D95G	1	.	.	283	285	GGC	577	579	GGC	184;185;189	G;G,A;C	168;169,1;173	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	539	1676	mtrR	633	633	99.84	mtrR.l15.c30.ctg.1	1364	122.5	0	.	p	.	0	D79N	NONSYN	235	237	GAT	557	559	AAT	248;249;249	A,G;A;T	220,1;220;215	.	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	539	1676	mtrR	633	633	99.84	mtrR.l15.c30.ctg.1	1364	122.5	1	SNP	p	G45D	0	.	.	133	135	GGC	455	457	GGC	225;227;224	G;G;C,T	207;208;207,1	mtrR.WHO_U_01459:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	764	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c30.ctg.1	974	77.9	0	.	n	.	0	A197.	DEL	197	197	A	542	542	A	176	A	169	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4912	parC	2304	2304	99.87	parC.l6.c30.ctg.1	2986	163.9	0	.	p	.	0	E91G	NONSYN	271	273	GAG	608	610	GGG	206;202;202	G;G;G	193;189;189	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4912	parC	2304	2304	99.87	parC.l6.c30.ctg.1	2986	163.9	1	SNP	p	D86N	0	.	.	256	258	GAC	593	595	GAC	204;204;204	G;A;C	188;185;189	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4912	parC	2304	2304	99.87	parC.l6.c30.ctg.1	2986	163.9	1	SNP	p	S87I	0	.	.	259	261	AGT	596	598	AGT	207;205;206	A;G;T	190;188;187	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4912	parC	2304	2304	99.87	parC.l6.c30.ctg.1	2986	163.9	1	SNP	p	S87R	0	.	.	259	261	AGT	596	598	AGT	207;205;206	A;G;T	190;188;187	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4912	parC	2304	2304	99.87	parC.l6.c30.ctg.1	2986	163.9	1	SNP	p	S87W	0	.	.	259	261	AGT	596	598	AGT	207;205;206	A;G;T	190;188;187	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4912	parC	2304	2304	99.87	parC.l6.c30.ctg.1	2986	163.9	1	SNP	p	S88P	0	.	.	262	264	TCC	599	601	TCC	204;206;208	T;C;C	188;191;191	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4546	parE	1986	1986	99.95	parE.l15.c17.ctg.1	2533	178.6	0	.	p	.	0	R427H	NONSYN	1279	1281	CGC	1541	1543	CAC	207;202;202	C;A,G;C	186;177,1;184	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4546	parE	1986	1986	99.95	parE.l15.c17.ctg.1	2533	178.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1490	1492	GGC	217;214;214	G;G;C	196;189;190	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.44.001	penA.44.001	1	1	27	4126	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2293	179.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1240	1242	GCA	233;233;231	G;C;A	214;216;216	penA.44.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	4126	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2293	179.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1243	1245	ATC	233;232;234	A;T;C	215;214;215	penA.44.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	4126	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2293	179.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1255	1257	GTG	234;235;237	G;T;G	214;214;215	penA.44.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	4126	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2293	179.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1255	1257	GTG	234;235;237	G;T;G	214;214;215	penA.44.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	4126	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2293	179.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1759	1761	ACC	207;210;210	A;C;C	187;192;194	penA.44.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	4126	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2293	179.0	1	SNP	p	T502V	0	.	.	1504	1506	ACG	1813	1815	ACG	201;201;202	A,G;C;G	164,1;168;164	penA.44.001:1:1:T502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	4126	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2293	179.0	1	SNP	p	T502P	0	.	.	1504	1506	ACG	1813	1815	ACG	201;201;202	A,G;C;G	164,1;168;164	penA.44.001:1:1:T502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	4126	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2293	179.0	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1936	1938	GGC	176;177;177	G;G;C	159;161;161	penA.44.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	4126	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2293	179.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1945	1947	GGC	185;184;180	G;G;C	168;168;163	penA.44.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.44.001	penA.44.001	1	1	27	4126	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2293	179.0	1	SNP	p	L552S	0	.	.	1654	1656	CTG	1963	1965	CTG	163;163;161	C,G;TG,TGG;G	124,3;125,2;122	penA.44.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5840	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3072	189.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1593	1595	CCG	203;207;209	C;C;G	176;185;182	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2512	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1831	136.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	530	530	C	187	C	165	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2670	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1632	163.0	1	SNP	p	G120K	1	.	.	358	360	AAG	641	643	AAG	214;216;220	A;A;G	198;201;201	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2670	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1632	163.0	1	SNP	p	A121N	1	.	.	361	363	AAC	644	646	AAC	222;224;225	A;A;C	204;208;210	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2670	porB1b	1038	1038	100.0	porB1b.l6.c4.ctg.1	1632	163.0	1	SNP	p	N121D	0	.	.	361	363	AAC	644	646	AAC	222;224;225	A;A;C	204;208;210	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	10352	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4763	216.7	1	SNP	p	H553N	0	.	.	1657	1659	CAT	1960	1962	CAT	251;252;249	C;A;T	224;226;226	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1114	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1004	110.6	1	SNP	p	V57M	1	.	.	169	171	ATG	542	544	ATG	228;226;227	A;T;G	205;204;205	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
